| Joanna Lee Berry, FNP | |
|
101 E Brunson St Ste 200, Enterprise, AL 36330-2500 | |
| (334) 393-3686 | |
| (334) 347-4096 |
| Full Name | Joanna Lee Berry |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 13 Years |
| Location | 101 E Brunson St Ste 200, Enterprise, Alabama |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164783502 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 1-105643 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Flowers Hospital | Dothan, AL | Hospital |
| Medical Center Enterprise | Enterprise, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Professional Medical Associates Pc | 3375574106 | 7 |
News Archive
The prevalence of both obesity and back pain in developing nations has reached alarming levels. According to recent statistics, more than one-third of U.S. adults - over 72 million people were obese in 2005-2006. Of these, 33.3 percent were men and 35.3 percent were women. Especially alarming is that obesity has not decreased among teenagers - the rates remain essentially unchanged in 2005-2006 from the 2003-2004 estimates, at 17 percent.
California Gov. Jerry Brown describes implementing the expansion as "incredibly complex," while Michigan Gov. Rick Snyder sees it an opportunity to address gaps in the mental health system. In Arizona, meanwhile, the expansion is framed as an immigration issue.
Development of an effective vaccine for malaria is a step closer following identification of a key pathway used by the malaria parasite to infect human cells. The discovery, by researchers at The Walter and Eliza Hall Institute in Melbourne, Australia, provides a new vaccine target through which infection with the deadly disease could be prevented.
MicuRx Pharmaceuticals, Inc., a privately-held biopharmaceutical company developing next-generation antibiotics, today announced that it has filed an Investigational New Drug (IND) application with the State Food and Drug Administration (SFDA) in China for MRX-I, its first development-stage antibiotic drug candidate. MRX-I, an orally-administered oxazolidinone, targets multi-drug resistant Gram-positive bacteria including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE).
› Verified 9 days ago
| Entity Name | Professional Medical Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063476836 PECOS PAC ID: 3375574106 Enrollment ID: O20050822001085 |
News Archive
The prevalence of both obesity and back pain in developing nations has reached alarming levels. According to recent statistics, more than one-third of U.S. adults - over 72 million people were obese in 2005-2006. Of these, 33.3 percent were men and 35.3 percent were women. Especially alarming is that obesity has not decreased among teenagers - the rates remain essentially unchanged in 2005-2006 from the 2003-2004 estimates, at 17 percent.
California Gov. Jerry Brown describes implementing the expansion as "incredibly complex," while Michigan Gov. Rick Snyder sees it an opportunity to address gaps in the mental health system. In Arizona, meanwhile, the expansion is framed as an immigration issue.
Development of an effective vaccine for malaria is a step closer following identification of a key pathway used by the malaria parasite to infect human cells. The discovery, by researchers at The Walter and Eliza Hall Institute in Melbourne, Australia, provides a new vaccine target through which infection with the deadly disease could be prevented.
MicuRx Pharmaceuticals, Inc., a privately-held biopharmaceutical company developing next-generation antibiotics, today announced that it has filed an Investigational New Drug (IND) application with the State Food and Drug Administration (SFDA) in China for MRX-I, its first development-stage antibiotic drug candidate. MRX-I, an orally-administered oxazolidinone, targets multi-drug resistant Gram-positive bacteria including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE).
› Verified 9 days ago
| Entity Name | Southern Alabama Physicians, Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467701490 PECOS PAC ID: 0345499562 Enrollment ID: O20121003000896 |
News Archive
The prevalence of both obesity and back pain in developing nations has reached alarming levels. According to recent statistics, more than one-third of U.S. adults - over 72 million people were obese in 2005-2006. Of these, 33.3 percent were men and 35.3 percent were women. Especially alarming is that obesity has not decreased among teenagers - the rates remain essentially unchanged in 2005-2006 from the 2003-2004 estimates, at 17 percent.
California Gov. Jerry Brown describes implementing the expansion as "incredibly complex," while Michigan Gov. Rick Snyder sees it an opportunity to address gaps in the mental health system. In Arizona, meanwhile, the expansion is framed as an immigration issue.
Development of an effective vaccine for malaria is a step closer following identification of a key pathway used by the malaria parasite to infect human cells. The discovery, by researchers at The Walter and Eliza Hall Institute in Melbourne, Australia, provides a new vaccine target through which infection with the deadly disease could be prevented.
MicuRx Pharmaceuticals, Inc., a privately-held biopharmaceutical company developing next-generation antibiotics, today announced that it has filed an Investigational New Drug (IND) application with the State Food and Drug Administration (SFDA) in China for MRX-I, its first development-stage antibiotic drug candidate. MRX-I, an orally-administered oxazolidinone, targets multi-drug resistant Gram-positive bacteria including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE).
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Joanna Lee Berry, FNP 101 E Brunson St, Ste 200, Enterprise, AL 36330-2500 Ph: (334) 347-0584 | Joanna Lee Berry, FNP 101 E Brunson St Ste 200, Enterprise, AL 36330-2500 Ph: (334) 393-3686 |
News Archive
The prevalence of both obesity and back pain in developing nations has reached alarming levels. According to recent statistics, more than one-third of U.S. adults - over 72 million people were obese in 2005-2006. Of these, 33.3 percent were men and 35.3 percent were women. Especially alarming is that obesity has not decreased among teenagers - the rates remain essentially unchanged in 2005-2006 from the 2003-2004 estimates, at 17 percent.
California Gov. Jerry Brown describes implementing the expansion as "incredibly complex," while Michigan Gov. Rick Snyder sees it an opportunity to address gaps in the mental health system. In Arizona, meanwhile, the expansion is framed as an immigration issue.
Development of an effective vaccine for malaria is a step closer following identification of a key pathway used by the malaria parasite to infect human cells. The discovery, by researchers at The Walter and Eliza Hall Institute in Melbourne, Australia, provides a new vaccine target through which infection with the deadly disease could be prevented.
MicuRx Pharmaceuticals, Inc., a privately-held biopharmaceutical company developing next-generation antibiotics, today announced that it has filed an Investigational New Drug (IND) application with the State Food and Drug Administration (SFDA) in China for MRX-I, its first development-stage antibiotic drug candidate. MRX-I, an orally-administered oxazolidinone, targets multi-drug resistant Gram-positive bacteria including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE).
› Verified 9 days ago
Ms. Julie Frances Hughes, C.P.N.P. Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 101 Professional Ln, Enterprise, AL 36330 Phone: 334-393-7337 | |
Jessica E Poitevint, CRNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 105 E Watts St, Enterprise, AL 36330 Phone: 334-393-5437 Fax: 334-393-4185 | |
Samantha Elizabeth Pickett, CRNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 806 Glover Ave Ste A, Enterprise, AL 36330 Phone: 334-475-2680 Fax: 334-475-2681 | |
Millicent R Harrison, CRNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 105 E Watts St, Enterprise, AL 36330 Phone: 334-393-5437 Fax: 334-393-4185 | |
Amber Amuso Williams, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 101 Professional Ln, Enterprise, AL 36330 Phone: 334-347-3404 | |
Neysa Hernandez, C.R.N.P. Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 2841 Neil Metcalf Rd, Enterprise, AL 36330 Phone: 334-347-9574 Fax: 334-347-7104 | |
Anna Jane Brown Smith, FNP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 526 Boll Weevil Cir, Enterprise, AL 36330 Phone: 334-308-1166 |